Related Experiment Video
Updated: Jun 13, 2026

14:03
Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety
Published on: July 24, 2011
15.6K
TDP-43 promotes efficient HSV-1 replication in human DRG-derived neurons
Shirley E Braspenning1, Denise Ohnezeit1, Olivia A DeGulis1
1Department of Microbiology, New York University School of Medicine, New York, New York, USA.
Journal of Virology
|December 4, 2025
Summary
TAR DNA-binding protein 43 (TDP-43) is crucial for herpes simplex virus type-1 (HSV-1) replication in neurons, but not other cells. Depleting TDP-43 impairs HSV-1 gene expression and splicing, suggesting it as an antiviral target.
Area of Science:
- Neurovirology
- Molecular Biology
- RNA Biology
Background:
- TAR DNA-binding protein 43 (TDP-43) is vital for RNA processing and neuronal homeostasis.
- TDP-43 aggregates are implicated in neurodegenerative diseases like ALS.
- Herpes simplex virus type-1 (HSV-1) is a neurotropic pathogen linked to neurodegeneration.
Purpose of the Study:
- To investigate the role of TDP-43 in HSV-1 infection across different cell types.
- To determine if TDP-43 influences viral replication and gene expression in neurons.
Main Methods:
- HSV-1 infection assays in epithelial cells, fibroblasts, and neuron-derived HD10.6 cells.
- TDP-43 depletion using RNA interference.
- Analysis of viral replication via multicycle growth experiments.
- Nanopore direct RNA sequencing to assess viral mRNA processing.
Main Results:
- TDP-43 depletion did not affect HSV-1 replication in epithelial cells or fibroblasts.
- HSV-1 replication was significantly reduced in TDP-43-depleted neuron-derived HD10.6 cells.
- TDP-43 depletion impaired viral immediate-early gene expression and caused intron retention in ICP0 and UL15 viral genes.
Conclusions:
- TDP-43 is essential for efficient HSV-1 replication specifically in neuronal cells.
- TDP-43 influences HSV-1 gene expression and mRNA splicing, impacting viral propagation.
- Targeting TDP-43 may offer a novel antiviral strategy against severe HSV-1 infections.

